Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

TB-500 Versus Proven Hair Loss Treatments — A Practical Comparison

Before considering TB-500 for hair thinning, understand how it compares to interventions with established clinical evidence. TB-500 (2mg 2x/week) VEGF upregulation, stem cell migration, inflammation modulation Case reports and observational series. No RCTs for

This comparison does not assign a generated winner or score.

  • Before considering TB-500 for hair thinning, understand how it compares to interventions with established clinical evidence.
  • TB-500 (2mg 2x/week)
  • VEGF upregulation, stem cell migration, inflammation modulation
  • Case reports and observational series. No RCTs for alopecia
  • 8–12 weeks for measurable density change (if effective)
  • $180–$280/month
  • Experimental adjunct with plausible mechanism but no standalone efficacy data for androgenic alopecia. Rational only as part of multi-modal protocol
  • Finasteride (1mg daily)
  • 5-alpha reductase inhibition (reduces scalp DHT by ~70%)
  • Multiple Phase III RCTs; FDA-approved since 1997
  • 6–12 months for visible regrowth
  • $15–$35/month (generic)
  • Gold standard for androgenic alopecia in men. Directly targets hormonal driver; contraindicated in women of childbearing potential
  • Minoxidil 5% (topical 2x daily)
  • KATP channel opening (follicular vasodilation), possible prostaglandin synthesis
  • FDA-approved 1988; decades of clinical use
  • 4–6 months for regrowth
  • $10–$25/month
  • Proven efficacy for vertex and frontal thinning; works independently of androgen signalling; requires continuous use
  • Low-Level Laser Therapy (LLLT)
  • Mitochondrial cytochrome c oxidase activation, ATP production
  • FDA-cleared devices; limited but positive RCT data
  • 6–9 months
  • $200–$800 upfront (device cost)
  • Modest efficacy (mean 15–20 hairs/cm² increase); best as adjunct; requires consistent 15–20 min sessions 3x/week
  • Platelet-Rich Plasma (PRP)
  • Growth factor delivery (PDGF, TGF-beta, VEGF) from autologous platelets
  • Mixed RCT results; efficacy depends on preparation protocol
  • 3–6 months (after 3 monthly sessions)
  • $500–$1,500/session
  • Variable outcomes; may work for early-stage thinning; mechanism overlaps with TB-500 (VEGF) but delivered via concentrated autologous factors
  • Microneedling (1.5mm depth)
  • Wounding-induced growth factor release, stem cell activation
  • Positive RCTs when combined with minoxidil
  • 6–12 weeks for visible response
  • $150–$300/session or $80 DIY dermaroller
  • Synergistic with topical treatments; improves absorption and triggers endogenous repair pathways similar to TB-500's proposed effects
  • If the goal is reversing androgenic alopecia, finasteride (or dutasteride for more aggressive DHT suppression) plus minoxidil remains the evidence-based foundation. TB-500 becomes relevant when inflammation, poor wound healing, or vascular insufficiency are suspected contributors. Contexts where its mechanism directly addresses the limiting factor.
More references

Related material